Class information for:
Level 3: CLOPIDOGREL//PLATELETS//PRASUGREL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
189 51017 36.4 73%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 4)


ID, lev.
above		 Publications Label for level above
0 3633673 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED

Classes in level below (level 2)


ID, lev.
below		 Publications Label for level below
202 20434 CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE
670 12541 CYCLOOXYGENASE 2//COX 2//CYCLOOXYGENASE
860 10928 5 LIPOXYGENASE//EXPT THER EUT REPERFUS INJURY//LEUKOTRIENES
2356 3923 I EM NEURODEGENERAT BRAIN//BERAPROST SODIUM//IBUDILAST
3021 2041 GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO
3413 1150 CILOSTAZOL//CLIN PHARMACOKINET PHARMACODYNAM METAB//AZECINES

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 CLOPIDOGREL Author keyword 1215 59% 3% 1380
2 PLATELETS Author keyword 607 25% 4% 2081
3 PRASUGREL Author keyword 566 79% 1% 362
4 ASPIRIN RESISTANCE Author keyword 526 89% 0% 235
5 MEAN PLATELET VOLUME Author keyword 486 70% 1% 402
6 ASPIRIN Author keyword 403 26% 3% 1359
7 TICAGRELOR Author keyword 378 76% 1% 264
8 CYCLOOXYGENASE 2 Author keyword 319 29% 2% 924
9 PLATELET AGGREGATION Author keyword 309 29% 2% 896
10 CILOSTAZOL Author keyword 303 62% 1% 316

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 CLOPIDOGREL 1215 59% 3% 1380 Search CLOPIDOGREL Search CLOPIDOGREL
2 PLATELETS 607 25% 4% 2081 Search PLATELETS Search PLATELETS
3 PRASUGREL 566 79% 1% 362 Search PRASUGREL Search PRASUGREL
4 ASPIRIN RESISTANCE 526 89% 0% 235 Search ASPIRIN+RESISTANCE Search ASPIRIN+RESISTANCE
5 MEAN PLATELET VOLUME 486 70% 1% 402 Search MEAN+PLATELET+VOLUME Search MEAN+PLATELET+VOLUME
6 ASPIRIN 403 26% 3% 1359 Search ASPIRIN Search ASPIRIN
7 TICAGRELOR 378 76% 1% 264 Search TICAGRELOR Search TICAGRELOR
8 CYCLOOXYGENASE 2 319 29% 2% 924 Search CYCLOOXYGENASE+2 Search CYCLOOXYGENASE+2
9 PLATELET AGGREGATION 309 29% 2% 896 Search PLATELET+AGGREGATION Search PLATELET+AGGREGATION
10 CILOSTAZOL 303 62% 1% 316 Search CILOSTAZOL Search CILOSTAZOL

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 ANTIPLATELET THERAPY 522 40% 2% 1021
2 ASPIRIN 413 19% 4% 1941
3 STENT THROMBOSIS 382 66% 1% 358
4 ASPIRIN TREATED PATIENTS 360 96% 0% 108
5 CLOPIDOGREL 355 29% 2% 1028
6 NONSTEROIDAL ANTIINFLAMMATORY DRUGS 352 15% 4% 2179
7 PROSTANOID RECEPTORS 343 46% 1% 564
8 ASPIRIN RESISTANCE 335 68% 1% 292
9 ASPIRIN USE 326 56% 1% 392
10 OF CARE ASSAY 302 89% 0% 137

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 PLATELETS 410 45% 1% 694
2 THROMBOSIS RESEARCH 246 15% 3% 1478
3 ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH 240 50% 1% 342
4 PROSTAGLANDINS 160 29% 1% 472
5 PROSTAGLANDINS & OTHER LIPID MEDIATORS 155 29% 1% 449
6 THROMBOSIS AND HAEMOSTASIS 144 12% 2% 1136
7 PROSTAGLANDINS LEUKOTRIENES AND MEDICINE 113 33% 1% 286
8 PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 80 16% 1% 471
9 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 61 13% 1% 453
10 EICOSANOIDS 33 45% 0% 55

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Estimates of benefits and harms of prophylactic use of aspirin in the general population 2015 16 45 71%
Pro-resolving lipid mediators are leads for resolution physiology 2014 71 113 86%
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators 2008 805 109 88%
Novel antiplatelet agents in acute coronary syndrome 2015 8 153 78%
Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome 2015 8 134 75%
Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 1996 1433 66 91%
Prostaglandins and leukotrienes: Advances in eicosanoid biology 2001 1694 55 71%
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis 2010 345 35 86%
Cyclooxygenases 1 and 2 1998 1863 104 63%
Mean Platelet Volume: A Link Between Thrombosis and Inflammation? 2011 272 147 80%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EXPT THER EUT REPERFUS INJURY 172 56% 0.4% 212
2 MOL BEHAV BIOL 84 49% 0.2% 124
3 SINAI THROMBOSIS 47 64% 0.1% 46
4 AUSTRALIAN BLOOD DIS 41 35% 0.2% 98
5 CHEM 2 37 46% 0.1% 61
6 EXPT THER EUT PHARMACOINFORMAT 33 83% 0.0% 19
7 HEARTDRUG S 33 64% 0.1% 32
8 CARDIOPULM PHARMACOL 29 72% 0.0% 23
9 CLAUDE PEPPER 28 47% 0.1% 44
10 ANESTHESIOL PERIOPERAT PAIN MED 27 15% 0.3% 164

Related classes at same level (level 3)


Rank Relatedness score Related classes
1 0.0000002353 HAEMOPHILIA//HEMATOLOGY//THROMBOSIS AND HAEMOSTASIS
2 0.0000002286 SNAKE VENOM//SPHINGOSINE 1 PHOSPHATE//CERAMIDE
3 0.0000002181 CHRONIC GRANULOMATOUS DISEASE//RAMADAN//RAMADAN FASTING
4 0.0000002097 CD44//HYALURONAN//INTEGRIN
5 0.0000001974 HELICOBACTER PYLORI//HELICOBACTER//CAGA
6 0.0000001843 DOCOSAHEXAENOIC ACID//MICROALGAE//EICOSAPENTAENOIC ACID
7 0.0000001789 CARDIAC & CARDIOVASCULAR SYSTEM//CARDIOL//CAROTID ENDARTERECTOMY
8 0.0000001698 TRANSFUSION//VOX SANGUINIS//TRANSFUSION MEDICINE
9 0.0000001612 ENDOTHELIN//ENDOTHELIN 1//ENDOTHELIUM
10 0.0000001591 TOXIC EPIDERMAL NECROLYSIS//STEVENS JOHNSON SYNDROME//DRUG HYPERSENSITIVITY